During the past decade, Rheumatology Associates of North Alabama conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 28 clinical trials were completed, i.e. on average, 164.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 17 clinical trials were completed. i.e. 1700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rheumatology Associates of North Alabama" #1 sponsor was "Pfizer" with 12 trials, followed by "Bristol-Myers Squibb" with 11 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Purdue Pharma LP" with 3 trials sponsored and "Galapagos NV" with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rheumatology Associates of North Alabama" #1 collaborator was "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator and "IND 2 Results LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Rheumatology Associates of North Alabama" are "Rheumatoid Arthritis" (23 trials), "Arthritis, Rheumatoid" (5 trials), "Psoriatic Arthritis" (4 trials), "Ankylosing Spondylitis" (2 trials) and "Arthritis" (2 trials). Many other conditions were trialed in "Rheumatology Associates of North Alabama" in a lesser frequency.

Most popular intervention types in "Rheumatology Associates of North Alabama" are "Drug" (44 trials), "Biological" (9 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Methotrexate" (10 trials), "Abatacept" (7 trials), "Tocilizumab" (3 trials) and "Tofacitinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Rheumatology Associates of North Alabama" are 46 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Rheumatology Associates of North Alabama". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Rheumatology Associates of North Alabama, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Rheumatology Associates of North Alabama, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 2 trials that are defined as “Not Applicable".